Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer
Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Cancer | Cancer & Oncology | Erbitux | National Institutes of Health (NIH) | Oropharyngeal Cancer